Version 1
: Received: 31 January 2024 / Approved: 1 February 2024 / Online: 1 February 2024 (09:34:48 CET)
How to cite:
Alharbi, N.H.J. A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulation. Preprints2024, 2024020005. https://doi.org/10.20944/preprints202402.0005.v1
Alharbi, N.H.J. A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulation. Preprints 2024, 2024020005. https://doi.org/10.20944/preprints202402.0005.v1
Alharbi, N.H.J. A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulation. Preprints2024, 2024020005. https://doi.org/10.20944/preprints202402.0005.v1
APA Style
Alharbi, N.H.J. (2024). A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulation. Preprints. https://doi.org/10.20944/preprints202402.0005.v1
Chicago/Turabian Style
Alharbi, N.H.J. 2024 "A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulation" Preprints. https://doi.org/10.20944/preprints202402.0005.v1
Abstract
Incretin effect helps in regulating glucose homeostasis and maintaining glycaemic control within the human body. This effect is achieved by the two naturally occurring incretin hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Such hormones released by specialized entero-endocrine cells of the gastrointestinal tract cause insulin augmentation after food consumption. However, incretin effects are impaired in type 2 diabetic, primarily attributed to the deterioration of GLP-1 function along with decreased GLP-1 receptor expression. Targeting this hormone has, therefore, become an important therapeutic approach to treat this diabetic condition. Native GLP-1’s brief half-life and rapid proteolytic degradation have generated significant enthusiasm in uncovering the long-acting GLP-1 receptor (GLP-1R) agonists to manage type 2 diabetes. These synthetic peptides mimic the natural GLP-1 to activate GLP-1R and effectively exert various physiological benefits in terms of weight management, blood pressure, lipid profile, obesity and major adverse cardiovascular event. This review paper provides insights into the structure, function and expression of GLP-1 and its receptor. It also summarizes existing literature regarding different types of GLP-1 receptor agonists, their effects on blood pressure and how they exert their actions. While animal models have contributed significantly to this area of study, the scarcity of human studies is noted, indicating a need for more investigation in this domain. Expanding research in humans will help in comprehending the impact of GLP-1 receptor agonists on blood pressure regulation and their underlying mechanisms.
Medicine and Pharmacology, Medicine and Pharmacology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
